Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
Gandhi
Rishi K
RK
Department of Dermatology, Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA.
Pickup
Tiffany
T
Sheth
Pranav B
PB
D000068800:Etanercept; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept